Search

everythinglearnresearchcommunity

for

Search:↓

Low ferritin and vitamin D levels are linked to hair loss, suggesting the need for personalized nutrition and diagnostics.

Oral minoxidil significantly reduces hair shedding in women with chronic telogen effluvium.

Hair loss (telogen effluvium) cases rose during the pandemic, especially in Hispanic and non-White groups, and were linked to other health issues and COVID-19.

Low ferritin and vitamin D levels are linked to hair loss.

More people experience hair loss after recovering from COVID-19 in hospitals than in outpatient settings.

Most women in the study lost hair due to stress, fever, childbirth, surgery, or thyroid issues, with low hemoglobin levels also common.

Low iron levels and obesity are linked to chronic hair loss in women.

COVID-19 can cause hair loss due to stress, with inflammation markers like D-dimer levels playing a role.

Oral minoxidil effectively reduces hair shedding in women with chronic telogen effluvium.

Minoxidil treatment for hair loss can cause scalp allergy and severe hair loss.

Anagen effluvium is a reversible condition causing sudden hair loss, often due to chemotherapy or head radiation.

Platelet-rich plasma is a promising and safe treatment for increasing hair density and thickness in women with chronic telogen effluvium.

Diagnosing diffuse alopecia, a hair loss condition, can be challenging and may require a scalp biopsy or tracking the disease's progression when symptoms and skin tests aren't enough.

COVID-19 survivors working in healthcare may experience temporary hair loss.

CTE and FPHL are different hair loss types with unique causes.

Thyroid autoimmunity may be involved in some female hair loss, suggesting the need to test for thyroid antibodies in these patients.

Taking zinc supplements can help improve or cure hair loss caused by zinc deficiency.

One supplement improved hair loss and quality faster and more effectively than the other in treating telogen effluvium.

COVID-19 patients with hair loss experienced greater cognitive deficits and more symptoms of depression, anxiety, and stress.

5% topical minoxidil may help reduce hair loss and increase hair growth in telogen effluvium.

People with chronic hair loss often have lower Vitamin B12 levels.

Female pattern hair loss is common in women, treatable with medications, and can affect mental health.

Iron deficiency anemia may contribute to hair loss in women with Telogen effluvium.

Oral minoxidil effectively reduces hair shedding in women with CTE, with no major side effects.

Hair loss can occur about 4 weeks after scalp surgery but usually grows back within 3 months without treatment.

The study concluded that low iron and vitamin D levels in women might play a role in chronic hair loss, despite no significant difference between those with and without hair loss.

COVID-19 infection may cause significant hair loss, but full hair recovery is likely without special treatment.

The study found that it's hard to tell the difference between two types of hair loss, alopecia areata and telogen effluvium, by looking at symptoms and tissue samples.